Carolina doctors, students collaborate on COVID-19 treatment study
Posted Jun 14, 2020
In the ongoing battle against COVID-19, doctors are treating severely ill patients with various drugs, one of which is tocilizumab, which blocks the cytokine interleukin-6 (L-6) receptor. For the first time in the United States, researchers at the University of North Carolina report that the drug did not show clear benefit to 11 severely ill patients and should be used with caution.
(UNC.edu)
Related: Campus Connections
UNC Disc Golf Team Wins National ChampionshipCarolina Disc Golf is a club team dedicated to growing the game of disc golf. UNC traveled to Rock Hill, South Carolina last weekend to...
Wed Apr 24, 2024Multiple UNC Graduate School Programs Ranked in Nation’s Top 10
Several University of North Carolina graduate programs were ranked in the top 10 of their respective categories by the U.S. News & World Report this...
Sun Apr 21, 2024
Classey, Van Ord run away with Tar Heel 10 Miler victories
Former Wofford cross country runner Beck Classey of Greenville and accomplished marathoner Tristin Van Ord coasted to victories Saturday at the Tar Heel 10 Miler...
Sat Apr 20, 2024
UNC Alumna at Nike endows Carolina Covenant scholarship
Ilana Finley ’00 is creating her own Tar Heel legacy by endowing a scholarship through the Carolina Covenant. After graduating with a bachelor’s degree in...
Fri Apr 19, 2024